Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityOther Accumulated ExpensesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Argan (AGX) Accumulated Expenses: 2010-2025

Historic Accumulated Expenses for Argan (AGX) over the last 16 years, with Jan 2025 value amounting to $83.3 million.

  • Argan's Accumulated Expenses fell 14.35% to $67.1 million in Q4 2025 from the same period last year, while for Oct 2025 it was $67.1 million, marking a year-over-year decrease of 14.35%. This contributed to the annual value of $83.3 million for FY2025, which is 1.96% up from last year.
  • Per Argan's latest filing, its Accumulated Expenses stood at $83.3 million for FY2025, which was up 1.96% from $81.7 million recorded in FY2024.
  • Argan's Accumulated Expenses' 5-year high stood at $83.3 million during FY2025, with a 5-year trough of $49.9 million in FY2023.
  • Moreover, its 3-year median value for Accumulated Expenses was $81.7 million (2024), whereas its average is $71.6 million.
  • Per our database at Business Quant, Argan's Accumulated Expenses dropped by 6.47% in 2023 and then spiked by 63.88% in 2024.
  • Argan's Accumulated Expenses (Yearly) stood at $50.8 million in 2021, then grew by 5.05% to $53.3 million in 2022, then dropped by 6.47% to $49.9 million in 2023, then soared by 63.88% to $81.7 million in 2024, then grew by 1.96% to $83.3 million in 2025.